The estimated economic burden of genital herpes in the United States. An analysis using two costing approaches

BMC Infectious Diseases

Table 4 Epidemiology of genital herpes in the claims database

Age	Sex	Population	Prevalent GH		Incident GH		Recurrent GH		Active GH
			N	proportion/1,000	N	rate/1,000	N	rate/1,000	N	rate/1,000
0-20	Male	81,966	12	0.15	3	0.04	0	0	4	0.05
	Female	80,180	57	0.71	18	0.22	4	0.05	18	0.22
	Total	162,146	69	0.43	21	0.14	4	0.02	22	0.14
21-40	Male	70,026	141	2.01	32	0.46	21	0.30	58	0.83
	Female	84,067	455	5.41	105	1.25	42	0.50	162	1.93
	Total	154,093	596	3.87	137	0.89	63	0.41	220	1.43
41-60	Male	61,450	71	1.16	18	0.29	10	0.16	31	0.50
	Female	69,947	159	2.27	43	0.61	25	0.36	62	0.89
	Total	131,397	230	1.75	61	0.46	35	0.27	93	0.71
>60	Male	9,045	3	0.33	1	0.11	1	0.11	1	0.11
	Female	8,394	5	0.6	0	0	1	0.12	2	0.24
	Total	17,439	8	0.46	1	0.06	2	0.11	3	0.17
All	Male	222,487	227	1.02	53	0.24	32	0.14	94	0.42
	Female	242,588	676	2.79	167	0.69	72	0.30	244	1.01
	Total	465,075	903	1.94	220	0.47	104	0.22	338	0.73

ISSN: 1471-2334